Achilles Therapeutics plc (ACHL) — Analyst outlook / Analyst consensus target is. Based on 5 analyst ratings, the consensus is neutral — 2 Buy, 1 Hold, 2 Sell.
The consensus price target is $2.00, representing an upside of 35.1% from the current price $1.48.
ACHL Stock — 12-Month Price Forecast
$2.00
▲ +35.14% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for Achilles Therapeutics plc, the price target is $2.00.
The average price target represents a +35.14% change from the last price of $1.48.
ACHL Analyst Ratings
Buy
Based on 5 analysts giving stock ratings to Achilles Therapeutics plc in the past 3 months
